01
Identification
Patient identification
Candidate patients are identified by participating pharmacies, clinical staff or the Provider — the people already close to the medication and the chart.
Home / For Providers / Pharmacist-Led RPM/RTM
Line 02 — Provider programPharmacist-Led RPM & RTM
Turnkey Remote Patient Monitoring and Remote Therapeutic Monitoring — with pharmacists and clinical staff who handle the day-to-day, and a provider who keeps full clinical authority. Connected devices and medication follow-up turned into earlier intervention and recurring reimbursement, provided the data actually arrives and the interactive communication is actually documented.
The model — our infrastructure, your clinical authority
Paradygm gives Providers a turnkey operational infrastructure to run RPM and RTM programs without building an internal care-management department. We supply the staffing, software, device logistics, billing support and compliance workflow. You keep the medicine.
The line is bright and it doesn't move: the Provider retains full clinical authority. Patient eligibility and medical necessity, establishing the provider-patient relationship through the required telehealth or qualifying encounter, care plans and clinical decisions, supervision and escalation, and final billing approval all stay with the Provider. Paradygm provides administrative, operational, staffing, technology and logistics support — Paradygm does not practise medicine or direct clinical decision-making.
What our pharmacists actually do
Pharmacists are central to how this program is delivered — working under Provider supervision and pursuant to Provider-established care plans, never independently. Their day-to-day is exactly where a pharmacist's training does the most good:
- Medication adherence support — keeping patients on their regimen between visits.
- Medication-related patient education — helping patients understand what they're taking and why.
- Medication-therapy follow-up — the ongoing check-ins that turn a prescription into an outcome.
- Escalation — identifying clinically significant concerns and routing them to the supervising Provider.
Pharmacists and other clinical staff do not independently establish provider-patient relationships, determine medical necessity, create care plans, prescribe, diagnose, or approve billing. They support delegated engagement, monitoring, documentation and escalation — under the Provider's supervision.
RPM and RTM — and why the pharmacist fits RTM
Remote Patient Monitoring (RPM) is a Medicare Part B program that reimburses providers for collecting, monitoring and managing physiologic data — blood pressure, glucose, weight — from patients outside the clinical setting, using connected medical devices.
Remote Therapeutic Monitoring (RTM) covers non-physiologic data such as medication adherence, therapy response and respiratory or musculoskeletal status. RTM is the natural fit for a pharmacist-led model: medication and therapy adherence is precisely what a pharmacist follows up on. Running RPM and RTM together lets a practice monitor both the device readings and whether the treatment plan is actually being followed.
Together they let you monitor chronic conditions between visits, detect deterioration earlier, improve adherence, reduce ER visits and hospitalisations, and generate recurring monthly reimbursement.
Why Medicare built it
By 2015–2018 chronic disease prevalence kept rising, readmissions remained costly, access gaps persisted — and digital health technology finally matured. CMS recognised connected devices could provide real-time physiologic data, improve proactive care, reduce acute events and lower system-wide cost. RPM was formally expanded in 2019 with defined CPT codes covering device setup, data transmission and monitoring time; RTM followed to capture therapy and adherence data.
Who qualifies
Eligibility is broader than CCM. A patient needs to be a Medicare Part B beneficiary diagnosed with at least one acute or chronic condition that requires ongoing monitoring, using an FDA-defined medical device that electronically transmits data. RPM is condition-driven — it isn't limited to patients with two or more chronic diagnoses.
Common qualifying conditions: hypertension, diabetes, CHF, COPD, obesity, post-discharge monitoring and cardiac conditions.
What Medicare requires to bill
- FDA-qualified medical devices
- Electronic transmission of data
- 16 days of data per 30-day period (for 99454)
- Documented interactive communication (for 99457)
- Accurate time tracking
- Clinical oversight and supervision
- Proper patient consent
RPM and RTM are highly documentation-driven. Missed thresholds mean denied claims.
The operational reality
RPM looks simple — ship devices, monitor data. In practice it needs device sourcing and inventory management, patient onboarding and training, logistics and replacements, 16-day data tracking, pharmacist and nurse monitoring workflows, alert-management protocols, time documentation, billing integration, supervision standards and audit preparation.
The failures are predictable: patients not transmitting 16 days, devices sitting unused, no documented interactive communication, improper time tracking, billing without compliance confirmation. It is operationally intensive and logistics-heavy — which is exactly the part we own.
Profitability depends on operational precision. RPM 101 — Paradygm Health Group
A word on scrutiny
RPM has expanded rapidly since 2019 and attracted strong private equity interest — and, with it, closer CMS attention. It remains a high-growth Medicare program, but it's under active observation because of misuse and aggressive billing models.
High-risk areas include device qualification, data transmission validity, "phantom time" billing, missing interactive-communication documentation and improper supervision. Clawbacks tied to 16-day non-compliance are a live risk. A weak program can create material financial liability, which is precisely why we treat the logistics and the documentation as the product.
Where it leaves the practice
RPM and RTM create recurring revenue, improved disease control, increased patient engagement, earlier intervention and value-based readiness — and position you for risk contracts, ACO participation, population health management and multi-site scaling. It's both clinical infrastructure and revenue infrastructure.
How a patient moves through the program
The seven operational steps we run around your clinical decisions. Billing eligibility begins only after the Provider establishes the patient and enrollment is approved.
02
Education & consent
Patient education & preliminary consent
The patient is educated on what the program involves and gives preliminary consent before anything is set in motion.
03
Equipment
Equipment coordination
Paradygm and participating pharmacies handle device procurement, staging, setup and the training that goes with it.
04
Screening
Eligibility & program screening
Coverage and medical-necessity checks — including a duplicate-billing screen for existing RPM, RTM or CCM programs so nothing is billed twice.
05
Provider establishment
Provider telehealth establishment & start of care
The Provider establishes the patient through the required telehealth or qualifying encounter. Billing eligibility begins only after Provider establishment and enrollment approval.
06
Monitoring
Ongoing monitoring & support
Pharmacists and clinical staff run adherence support, education, follow-up and monitoring under Provider supervision — escalating anything clinically significant.
07
Billing & reporting
Billing cycle & reporting
Claims are prepared with the documentation to support them — and the Provider reviews and approves before anything is submitted.
The compliance safeguards built into the model
The program is designed to support compliance with the Corporate Practice of Medicine (CPOM) doctrine, the Anti-Kickback Statute (AKS), HIPAA, Medicare RPM/RTM requirements and state telehealth rules. It is designed to support compliance — it does not, by itself, guarantee it; compliance depends on how each Provider operates the program.
- Provider clinical independence — clinical authority and decision-making stay with the Provider.
- Fair-market-value compensation — structured to avoid improper inducement.
- Clinical-supervision requirements — all clinical staff work under Provider supervision and Provider-established care plans.
- Duplicate-billing-prevention workflows — screening for existing RPM, RTM and CCM enrollment before start of care.
- Provider billing-approval authority — the Provider reviews and approves every claim before submission.
- State-licensure verification — participating staff are verified against the states in which they operate.
Provider FAQ
Who owns the patient relationship and clinical decisions?
You do. The Provider retains full clinical authority — eligibility, medical necessity, care plans, supervision, escalation and billing approval. Paradygm never directs clinical decision-making.
Does Paradygm practise medicine?
No. Paradygm provides administrative, operational, staffing, billing, technology and logistics support only. We do not practise medicine or make clinical decisions.
Can the pharmacists or clinical staff manage patients on their own?
No. Clinical staff — pharmacists, RNs, LPNs, respiratory therapists, CMAs, care coordinators — work under your supervision and your care plans. They do not independently establish relationships, determine medical necessity, create care plans, prescribe, diagnose or approve billing.
How is duplicate billing prevented?
Before start of care we screen for existing RPM, RTM and CCM enrollment so a patient isn't billed into two overlapping programs. Every claim is also reviewed and approved by you before submission.
How do escalations work?
When a pharmacist or staff member identifies a clinically significant concern, defined escalation workflows route it to the supervising Provider — the clinical call is always yours.
Who handles the devices?
Paradygm and participating pharmacies handle procurement, staging, inventory, setup, training and replacements — the logistics that quietly sink most programs.
Can the Provider participate remotely?
Yes — subject to state licensure, telehealth rules and payer requirements. Establishment of care still happens through the required telehealth or qualifying encounter.
For pharmacists & pharmacies
A way to participate in monitoring — under provider supervision.
If you're a pharmacist or a pharmacy, this program is a way to put your medication expertise to work inside a compliant, provider-supervised structure. You focus on what you're trained for — adherence support, medication education, medication-therapy follow-up and flagging concerns for the Provider — while Paradygm handles recruitment, onboarding, training, non-clinical supervision, devices and the billing workflow. Participating pharmacies also help identify candidate patients and support device coordination locally.
You don't take on clinical authority you shouldn't, and you don't have to build the operational apparatus yourself. Talk to us about participating →
Program scale — Paradygm's published model
Assumes $100 per patient per month, 12 months of active billing, and a 40% gross margin with device ownership, clinical staffing, logistics and platform costs included. Illustrative, not a quote.
| Panel size | Annual revenue | Gross profit (40%) | Typical fit |
|---|---|---|---|
| 200 patients | $240,000 | $96,000 | Independent practice |
| 500 patients | $600,000 | $240,000 | Established practice |
| 5,000 patients | $6,000,000 | $2,400,000 | Multi-site / large group |
Let's talk
Monitoring is easy. Compliant monitoring isn't.
We'll walk you through what a defensible RPM and RTM program looks like for your patients — the pharmacist-led delivery, the devices, the logistics and the documentation, all of it.